Your browser doesn't support javascript.
loading
FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Follicular Lymphoma.
Bouchkouj, Najat; Zimmerman, Megan; Kasamon, Yvette L; Wang, Cong; Dai, Tianjiao; Xu, Zhenzhen; Wang, Xiaofei; Theoret, Marc; Purohit-Sheth, Tejashri; George, Bindu.
  • Bouchkouj N; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Zimmerman M; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Kasamon YL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Wang C; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Dai T; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Xu Z; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Wang X; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Theoret M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Purohit-Sheth T; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • George B; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
Oncologist ; 27(7): 587-594, 2022 07 05.
Article en En | MEDLINE | ID: mdl-35403693
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Productos Biológicos / Linfoma Folicular / Linfoma de Células B Grandes Difuso Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Productos Biológicos / Linfoma Folicular / Linfoma de Células B Grandes Difuso Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article